SAN DIEGO, Sept. 19, 2017 /PRNewswire/ -- Pfenex Inc.
(NYSE MKT: PFNX) announced today that it will be presenting at the
Cantor Fitzgerald Global Healthcare Conference on September 27th, 2017 at 4:00 pm ET. The conference will be held at the
Intercontinental New York Barclay Hotel, New York. The
presentation will be webcast and available for replay in the
Investor Section of Pfenex's website www.pfenex.com.
Pfenex investors and others should note that we announce
material information to the public about the Company through a
variety of means, including our website (http://www.pfenex.com/),
our investor relations website (http://pfenex.investorroom.com/),
press releases, SEC filings, public conference calls, corporate
Twitter account (https://twitter.com/pfenex), Facebook page
(https://www.facebook.com/Pfenex-Inc-105908276167776/timeline/),
and LinkedIn page (https://www.linkedin.com/company/pfenex-inc) in
order to achieve broad, non-exclusionary distribution of
information to the public and to comply with our disclosure
obligations under Regulation FD. We encourage our investors and
others to monitor and review the information we make public in
these locations as such information could be deemed to be material
information. Please note that this list may be updated from time to
time.
About Pfenex Inc.
Pfenex Inc. is a clinical-stage biotechnology company engaged in
the development of biosimilar therapeutics and high-value and
difficult to manufacture proteins. The company's lead product
candidates are PF708, a therapeutic equivalent candidate to Forteo
(teriparatide) for the treatment of osteoporosis, and PF582, a
biosimilar candidate to Lucentis (ranibizumab), for the potential
treatment of patients with retinal diseases. Pfenex has leveraged
its Pfēnex Expression
Technology® platform to build a pipeline of
product candidates and preclinical products under development
including other biosimilars, as well as vaccines, therapeutic
equivalents to reference listed drug products, and next generation
biologics.
View original content with
multimedia:http://www.prnewswire.com/news-releases/pfenex-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-27th-2017-300521505.html
SOURCE Pfenex Inc.